John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 92,818 shares at $1.83 ($170K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($170k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.83 | 46,409 | $85K | 50.0% |
| 2 | $1.83 | 46,409 | $85K | 50.0% |
| Total | $1.83 avg | 92,818 | $170K | 100% |
| Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $115K | — | Filing → |